1. Home
  2. JRVR vs DRTS Comparison

JRVR vs DRTS Comparison

Compare JRVR & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRVR
  • DRTS
  • Stock Information
  • Founded
  • JRVR 2002
  • DRTS 2015
  • Country
  • JRVR Bermuda
  • DRTS Israel
  • Employees
  • JRVR N/A
  • DRTS N/A
  • Industry
  • JRVR Property-Casualty Insurers
  • DRTS Medical/Dental Instruments
  • Sector
  • JRVR Finance
  • DRTS Health Care
  • Exchange
  • JRVR Nasdaq
  • DRTS Nasdaq
  • Market Cap
  • JRVR 270.4M
  • DRTS 300.2M
  • IPO Year
  • JRVR 2005
  • DRTS N/A
  • Fundamental
  • Price
  • JRVR $5.16
  • DRTS $3.86
  • Analyst Decision
  • JRVR Buy
  • DRTS Strong Buy
  • Analyst Count
  • JRVR 4
  • DRTS 1
  • Target Price
  • JRVR $6.06
  • DRTS $9.00
  • AVG Volume (30 Days)
  • JRVR 309.9K
  • DRTS 64.0K
  • Earning Date
  • JRVR 11-10-2025
  • DRTS 08-11-2025
  • Dividend Yield
  • JRVR 0.75%
  • DRTS N/A
  • EPS Growth
  • JRVR N/A
  • DRTS N/A
  • EPS
  • JRVR N/A
  • DRTS N/A
  • Revenue
  • JRVR $665,342,000.00
  • DRTS N/A
  • Revenue This Year
  • JRVR $2.19
  • DRTS N/A
  • Revenue Next Year
  • JRVR $7.93
  • DRTS N/A
  • P/E Ratio
  • JRVR N/A
  • DRTS N/A
  • Revenue Growth
  • JRVR N/A
  • DRTS N/A
  • 52 Week Low
  • JRVR $3.00
  • DRTS $2.11
  • 52 Week High
  • JRVR $7.19
  • DRTS $4.39
  • Technical
  • Relative Strength Index (RSI)
  • JRVR 37.75
  • DRTS 67.65
  • Support Level
  • JRVR $5.20
  • DRTS $3.51
  • Resistance Level
  • JRVR $5.43
  • DRTS $3.99
  • Average True Range (ATR)
  • JRVR 0.19
  • DRTS 0.17
  • MACD
  • JRVR -0.04
  • DRTS 0.03
  • Stochastic Oscillator
  • JRVR 4.58
  • DRTS 84.57

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

Share on Social Networks: